Milnacipran ( DrugBank: Milnacipran )

---

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	2
49	全身性エリテマトーデス	1

46. 悪性関節リウマチ

---

臨床試験数 : 4,325 /  薬物数 : 2,671 - (DrugBank : 417) / 標的遺伝子数 : 187 - 標的パスウェイ数 : 224

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01207453 (ClinicalTrials.gov)	January 2011	21/9/2010	Milnacipran in the Treatment of Widespread, Non-Joint Pain in Rheumatoid Arthritis	Milnacipran in the Treatment of Widespread, Non-Joint Pain in Rheumatoid Arthritis	Arthritis, Rheumatoid	Drug: Milnacipran;Drug: Placebo	Brigham and Women's Hospital	Forest Laboratories;National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	Completed	24 Years	N/A	All	49	Phase 4	United States
2	NCT01225991 (ClinicalTrials.gov)	November 2010	20/10/2010	Milnacipran for Treatment of Pain in Older Adults With Rheumatoid Arthritis	An Open-label Trial of Milnacipran for the Treatment of Pain in Rheumatoid Arthritis (RA) in Older Adults	Rheumatoid Arthritis	Drug: Milnacipran	University of California, Los Angeles	Forest Laboratories	Completed	50 Years	N/A	All	18	Phase 4	United States

49. 全身性エリテマトーデス

---

臨床試験数 : 946 /  薬物数 : 722 - (DrugBank : 186) / 標的遺伝子数 : 117 - 標的パスウェイ数 : 199

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01359826 (ClinicalTrials.gov)	October 2011	19/4/2011	The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients	The Effect of Milnacipran on Fatigue and Quality of Life in a Lupus Cohort	Systemic Lupus Erythematosus;Widespread Pain;Fibromyalgia	Drug: Milnacipran	Loma Linda University	Forest Laboratories	Withdrawn	18 Years	N/A	Both	0	Phase 4	United States